Mehdi Gasmi is Director at Adverum Biotechnologies, Inc. (ADVM). They have made 7 open-market trades across 1 company since 2015, most recently 2020-07-20.
CIK 0001614875
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADVM | SELL | 2020-07-20 | 2020-07-22 | $17.60 | $88K | +4.0% | -24.5% | -32.1% |
| ADVM | SELL | 2020-06-22 | 2020-06-23 | $25.06 | $1.2M | -19.2% | -31.8% | -54.4% |
| ADVM | SELL | 2020-06-17 | 2020-06-18 | $25.01 | $563K | -14.6% | -28.9% | -47.5% |
| ADVM | SELL | 2020-06-15 | 2020-06-17 | $21.58 | $324K | -14.4% | -24.3% | -46.9% |
| ADVM | SELL · 10b5-1 | 2020-05-20 | 2020-05-22 | $20.02 | $100K | -2.5% | +23.2% | -36.8% |
| ADVM | SELL | 2020-05-05 | 2020-05-20 | $18.34 | $917K | +5.7% | +23.3% | -32.3% |
| ADVM | SELL | 2020-02-18 | 2020-02-20 | $16.23 | $81K | -18.6% | -33.9% | +26.9% |
| ADVM | SELL | 2020-02-12 | 2020-02-14 | $15.07 | $151K | -22.0% | -43.9% | +7.6% |
| [AAVL] | SELL · 10b5-1 | 2015-06-15 | 2015-06-17 | $39.86 | $20K | N/A | N/A | N/A |
| [AAVL] | SELL · 10b5-1 | 2015-06-08 | 2015-06-10 | $38.64 | $19K | N/A | N/A | N/A |
| [AAVL] | SELL · 10b5-1 | 2015-05-28 | 2015-05-29 | $38.02 | $19K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-05-28 | 2015-06-05 | $38.02 | $19K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-05-21 | 2015-05-22 | $38.87 | $19K | N/A | N/A | N/A |
| [AAVL] | SELL · 10b5-1 | 2015-05-14 | 2015-05-15 | $35.31 | $18K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-05-07 | 2015-05-08 | $33.28 | $17K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-04-28 | 2015-04-30 | $35.67 | $36K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-04-21 | 2015-04-23 | $39.21 | $39K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-04-14 | 2015-04-15 | $39.45 | $39K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-04-07 | 2015-04-08 | $38.61 | $347K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.